Linkage disequilibrium on the COMT gene in French schizophrenics and controls

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 88, Issue 5, 1999, Pages 452-457

  De Chaldee M ^a   Laurent, C ^a   Thibaut, F ^b   Martinez, M ^c   Samolyk, D ^a   Petit, M ^b   Campion, D ^b   Mallet, J ^a,d  

^a Lab Genet Molec N   (France)

^b CHS du Rouvray   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Association; Chromosome 22; COMT; Polymorphisms; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; ARTICLE; CATECHOLAMINE SYNTHESIS; CHROMOSOME 22; ENZYME ACTIVITY; ENZYME INDUCTION; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE STRAND CONFORMATION POLYMORPHISM;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; ADULT; ALLELES; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CHROMOSOMES, HUMAN, PAIR 22; EXONS; FEMALE; FRANCE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SCHIZOPHRENIA;

EID: 0033569736     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19991015)88:5<452::AID-AJMG2>3.0.CO;2-0     Document Type: Article

References (53)

1. American Psychiatric Association. 1987. Diagnostic and statistical manual of mental disorders, 3rd ed., rev. Washington, DC: APA.
2. Axelrod J, Tomchick R. 1958. Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233:702-705.
3. Baron M, Gruen R, Levitt M, Hunter C, Asnis L. 1984. Erythrocyte catechol-O-methyltransferase activity in schizophrenia: analysis of family data. Am J Psychiatry 141:29-32.
4. Carlson C, Papolos D, Pandita RK, Faedda GL, Veit S, Goldberg R, Shprintzen R, Kucherlapati R, Morrow B. 1997. Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders. Am J Hum Genet 60:851-859.
5. Carlsson A, Lindqvist M. 1963. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmac Toxicol 20:140-144.
6. Cavalli-Sforza LL, Menozzi P, Piazza A. 1994. The history and geography of human genes. Princeton, NJ: Princeton University Press, p 280-285.
7. Chen CH, Lee YR, Liu MY, Wei FC, Koong FJ, Hwu HG, Hsiao KJ. 1996. Identification of a Bgl I polymorphism of catechol-O-methyltransferaae gene, and association study with schizophrenia. Am J Med Genet 67: 556-559.
8. Chen CH, Lee YR, Wei FC, Koong FJ, Hwu HG, Hsiao KJ. 1997. Association study of Nla III and Msp I genetic polymorphisms of catechol-O-methyltransferase gene and susceptibility to schizophrenia. Biol Psychiatry 41:985-987.
9. Church GM, Gilbert W. 1984. Genomic sequencing. Proc Natl Acad Sci USA 81:1991.
10. Daniels JK, Williams NM, Williams J, Jones LA, Cardno AG, Murphy KC, Spurlock G, Riley B, Scambler P, Asherson P, McGuffin P, Owen MJ. 1996. No evidence for allelic association between schizophrenia and a polymorphism determining high or low COMT activity. Am J Psychiatry 153:268-270.
11. Dunham I, Collins J, Wadey R, Scambler P. 1992. Possible role for COMT in psychosis associated with velo-cardio-facial-syndrome. Lancet 340: 1361-1362.
12. Dutton CM, Paynton C, Sommer SS. 1993. General method for amplifying regions of very high G+C content. Nucl Acids Res 21:2953-2954.
13. Eberhard G, Ross S, Saaf J, Walhund B, Wetterburg L. 1989. Psychoses in twins: a 10-year clinical and biochemical follow-up study. Schizophr Res 2:367-374.
14. Floderus Y, Book JA, Wetterberg L. 1981. Erythrocyte catechol-O-methyltransferase activity in related families with schizophrenia. Clin Genet 19:386-389.
15. Fyer AJ, Endicott J, Manuzza S, Klein DF. 1985. Schedule for Affective Disorders and Schizophrenia, Lifetime Anxiety version. New York: State Psychiatric Institute.
16. Gottesman II, Shields J. 1967. A polygenic theory of schizophrenia. Proc Natl Acad Sci USA 58:199-205.
17. Gottesman II. 1991. Schizophrenia genesis. New York: W.H. Freeman.
18. Grossman MH, Emanuel BS, Budarf ML. 1992. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1→q11.2. Genomics 12:822-825.
19. Gutiérrez B, Bertranpetit J, Guillamat R, Vallès V, Arranz MJ, Kerwin R, Fañanás L. 1997. Association analysis of the catechol-O-methyl-transferase gene and bipolar affective disorder. Am J Psychiatry 154: 113-115.
20. Hauge XY, Grandy DK, Eubanks JH, Evans GA, Civelli O, Litt M. 1991. Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. Genomics 10:527-530.
21. Higuchi M, Wong C, Kochhan L, Olek K, Aronis S, Kasper CK, Kazazian HH Jr, Antonarakis SE. 1990. Characterization of mutations in the factor VIII gene by direct sequencing of amplified genomic DNA. Genomics 6:65-71.
22. Jorde LB. 1995, Linkage disequilibrium as a gene-mapping tool. Am J Hum Genet 56:11-14.
23. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, Gos A, Nestadt G, Wolyniec PS, Lasseter VK, Eisen H, Childs B, Kazazian HH, Kucherlapati R, Antonarakis SE, Pulver AE, Housman DE. 1995. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 92:7612-7616.
24. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, Gogos JA. 1997. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 94:4572-4575.
25. Karayiorgou M, Gogos JA, Galke BL, Wolyniec PS, Nestadt G, Antonarakis SE, Kazazian HH, Housman DE, Pulver AE. 1998. Identification of sequence variants and analysis of the role of the catechol-O-methyltransferase gene in schizophrenia susceptibility. Biol Psychiatry 43:425-431.
26. Kety SS, Wender P, Jacobsen B, Ingraham LJ, Jansson L, Faber B, Kinney DK. 1994. Mental illness in the biological and adoptive relatives of schizophrenic adoptees: replication of the Copenhagen study in the rest of Denmark. Arch Gen Psychiatr 51:442-455.
27. Kidd KK, Pakstis AJ, Castiglione CM, Kidd JR, Speed WC, Goldman D, Knowier WC, Lu RB, Bonne-Tamir B. 1996. DRD2 haplotypes containing the Taq I Al allele: implications for alcoholism research. Alcohol Clin Exp Res 20:697-705.
28. Koeberl DD, Bottema CDK, Buerstedde JM, Sommer SS. 1989. Functionally important regions of the factor IX gene have a low rate of polymorphism and CpG is a dramatic hotspot of germline mutation. Am J Hum Genet 45:448-457.
29. Kunugi H, Vallada HP, Sham PC, Hoda F, Arranz MJ, Li T, Nanko S, Murray RM, McGuffin P, Owen M, Gill M, Collier DA. 1997. Catechol-O-methyltransferase polymorphisms and schizophrenia. A transmission disequilibrium study in multiply affected families. Psychiatric Genet 7:97-101.
30. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. 1996. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
31. Lachman HM, Nolan KA, Mohr P, Saito T, Volavka J. 1998. Association between catechol-O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 155:835-837.
32. Lewander T, Von Pongracz G, Backstrom M, Wetterburg L. 1981. Dopamine metabolism in red blood cells in schizophrenia. Clin Genet 19: 410-413.
33. Li T, Sham PC, Vallada H, Xie T, Tang X, Murray RM, Liu X, Collier DA. 1996. Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatry Genet 6:131-133.
34. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melén K, Julkunen I, Taskinen J. 1995. Kinetics of human soluble and membrane bound catechol-O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202-4210.
35. Mallet J, Meloni R, Laurent C. 1994. Catecholamine metabolism and psychiatric or behavioral disorders. Curr Op Genet Dev 4:419-426.
36. McGue M, Gottesman II. 1991. The genetic epidemiology of schizophrenia and the design of linkage studies. Eur Arch Psychiatry Clin Neurosci 240:174-181.
37. Meloni R, Laurent C, Campion D, Ben Hadjali B, Thibaut F, Dollfus S, Petit M, Samolyk D, Martinez M, Poirier MF, Mallet J. 1995. A rare allele of a microsatellite located in the tyrosine hydroxylase gene found in schizophrenic patients. C R Acad Sci 318:803-809.
38. Neitzel H. 1986. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet 73:320-326.
39. Ohmori O, Shinkai T, Kojima H, Terao T, Suzuki T, Mita T, Abe K. 1998. Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neurosci Lett 243:109-112.
40. Orita M, Iwahana H, Kanazawa H, Hayashi K Sekiya T. 1989. Detection of polymorphisms of human DNA by gel electrophoresis as Single Strand Conformation Polymorphisms. Proc Natl Acad Sci USA 86: 2766-2770.
41. Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyniec PS, Morrow B, Karayiorgou M, Antonarakis SE, Housman D, Kucherlapati R. 1994. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 182:476-478.
42. Riley B, Mogudi-Carter M, Jenkins T, Williamson R. 1996. No evidence for linkage of chromosome 22 markers to schizophrenia in southern African Bantu-speaking families. Am J Med Genet 67:515-522.
43. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual, 2nd ed. New York: Cold Spring Harbor Laboratory Press.
44. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM. 1993. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 16:325-332.
45. Shprintzen RJ, Golberg RB, Lewin ML, Sidoti EJ, Berkman MD, Argamaso RV, Young D. 1978. A new syndrome involving cleft palate, cardia anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J 15:56-62.
46. Sobell JL, Heston LL, Sommer SS. 1992. Delineation of genetic predisposition to multifactorial disease: a general approach on the threshold of feasibility. Genomics 12:1-6.
47. Strous RD, Bark N, Parsia SS, Volavka J, Lachman HM. 1997a. Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res 69:71-77.
48. Strous RD, Bark N, Woerner M, Lachman HM. 1997b. Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia. Biol Psychiatry 41:493-495.
49. Tenhunen J, Salminen M, Lundström K, Kiviluoto T, Savolainen R, Ulmanen I. 1994. Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 223:1049-1059.
50. Thomson G. 1994. Identifying complex disease genes: progress and paradigms. Nature Genet 8:108-110.
51. Weeks D, Lathrop M. 1995. Polygenic disease: methods for mapping complex disease traits. TIG 11:513-519.
52. Winqvist R, Lundström K, Salminen M, Laatikainen M, Ulmanen I.1992. The human catechol-O-methyltransferase gene maps to band q11.2 of chromosome 22 and shows a frequent RFLP with Bgl I. Cytogenet Cell Genet 59:253-257.
53. Zerba KE, Kessling AM, Davignon J, Sing CF. 1991. Genetic structure and the search for genotype-phenotype relationships: an example from disequilibrium in the Apo B gene region. Genetics 129:525-533.